Provider Review · Updated November 2026

Hims Weight Loss Review 2026: A Different Program Than a Year Ago

Hims built its weight loss business on compounded semaglutide. After an FDA statement, an HHS referral to the DOJ and a Novo Nordisk lawsuit in early 2026, the company [changed course in March 2026](https://www.sec.gov/Archives/edgar/data/1773751/000177375126000033/ex991pressrelease.htm). It now offers brand-name Wegovy and Ozempic through a Novo Nordisk collaboration, and compounded GLP-1s only when a provider finds them clinically necessary. Here is what we could verify on Nov 4, 2026.

Quick Facts

What Hims Offers Now

Hims (branded as Hers for women) is part of Hims & Hers Health, a publicly traded telehealth company. Its quarterly report says subscribers grew to about 2.9 million as of June 30, 2026 across all categories.

The March 9, 2026 press release lists the Novo Nordisk products coming to the platform: Ozempic 0.5 mg, 1 mg and 2 mg injections, Wegovy 1.7 mg or 2.4 mg injections, and Wegovy 1.5 mg, 4 mg, 9 mg and 25 mg tablets. It says the company “will no longer advertise compounded GLP-1 offerings on its platform or in its marketing” and will offer compounded GLP-1s only to a limited set of patients whose provider finds them clinically necessary.

The June 2026 quarterly report adds that “we launched a membership program for our weight loss offerings.”

Pricing

We could not load hims.com on Nov 4, 2026 because the site blocked automated access. We are not listing Hims prices we could not confirm. On the Hims site, check the membership fee and the medication price separately.

For brand-name reference, here are the NovoCare self-pay prices for Wegovy as of Nov 4, 2026:

NovoCare says these prices apply through December 31, 2026 and may change. If you want tirzepatide, Zepbound self-pay through LillyDirect starts at $299/month for the 2.5 mg dose. Compare the total you would pay through Hims (membership plus medication) with buying direct.

The Regulatory History You Should Know

February 2025: The FDA declared the semaglutide shortage resolved, which narrowed when compounders could make copies of semaglutide.

September 2025: Hims & Hers says it received FDA warning letters about statements on its websites regarding compounded semaglutide products.

February 6, 2026: The FDA announced its intent to restrict GLP-1 ingredients used in non-FDA-approved compounded drugs that are mass-marketed, and named Hims & Hers. The company says HHS referred it to the DOJ for investigation that month.

February 9, 2026: Novo Nordisk sued Hims & Hers for patent infringement over compounded semaglutide, per the company’s quarterly report.

March 9, 2026: Hims & Hers announced the Novo Nordisk collaboration and the shift to brand-name GLP-1s. The release says Novo Nordisk was dismissing its lawsuit without prejudice.

For more on compounded vs brand-name medications, read our compounded vs brand-name guide.

How Hims Works

1. Fill out a health questionnaire. Medical history, current medications, weight, goals.
2. Provider review. Hims & Hers says customers reach licensed providers through video, phone, or store-and-forward (asynchronous) consultations.
3. Prescription. If appropriate, a brand-name GLP-1, or in limited cases a compounded product.
4. Ongoing support. The March 2026 release says the company continues to offer direct provider access, nutrition guidance and clinical check-ins.

Safety Notes

The Wegovy label carries a boxed warning for thyroid C-cell tumors. Do not use it if you or a family member has had medullary thyroid cancer or MEN 2. The label also warns about acute pancreatitis, and says to stop Wegovy at least 2 months before a planned pregnancy. Tell your prescriber about kidney problems, gallbladder disease, or any pancreatitis history, and follow their dosing schedule.

What I Like About Hims

Access to Brand-Name Wegovy, Including the Pill

The Novo Nordisk deal brings FDA-approved Wegovy pens and pills and Ozempic to the platform. If you want a pill instead of an injection, the Wegovy tablet is an approved option.

Scale and Provider Access

Hims & Hers is a large public company with consultations by video, phone or messaging. For people who want an app-based experience from an established company, that matters.

What Could Be Better

Regulatory Track Record

FDA warning letters in 2025, an FDA statement naming the company and an HHS referral to the DOJ in 2026 are a real history. The shift to brand-name drugs reduces some of that risk, but you should know it.

Prices Not Confirmed

We could not confirm current Hims prices. A membership plus brand-name medication may cost more than buying Wegovy directly through NovoCare, so compare before you sign up.

Tirzepatide Not Named

The March 2026 announcement covered Novo Nordisk products only. In the SURMOUNT-5 trial, tirzepatide produced a 20.2% mean weight loss versus 13.7% for semaglutide at 72 weeks. If you want tirzepatide, check whether Hims offers it or look at LillyDirect.

Who Hims Is Best For

Hims may fit if you:

• Want brand-name Wegovy (pen or pill) or Ozempic through a large telehealth app
• Prefer messaging or video visits over in-person care
• Are a man looking for a men-focused brand (Hers is the women’s brand)

Hims is not the best fit if you want compounded semaglutide (now limited), if you want tirzepatide, or if you want the lowest total price for Wegovy without a membership.

Hims vs. the Competition

Hims vs. Ro

Both now focus on brand-name GLP-1s. Ro also offers insurance help. Compare total monthly cost on each site. Full comparison

Hims vs. Found Health

Found pairs medication with coaching from obesity medicine clinicians. If coaching matters, Found is worth a look. Full comparison

Hims vs. Calibrate

Calibrate works with insurance, prescribes brand-name GLP-1s and includes a structured coaching program. See our Calibrate review.

The Bottom Line

Hims is no longer the compounded semaglutide program it was in 2025. It now leads with brand-name Wegovy and Ozempic, which removes much of the legal uncertainty around its old core plan. What we could not confirm is the price. Check the membership fee and medication cost on the Hims site and compare the total with NovoCare’s self-pay price before you sign up.

Compare all your options in our provider directory or see the best GLP-1 programs for 2026 ranked.

FAQ

Is Hims weight loss legit?

Hims & Hers Health is a publicly traded company (NYSE: HIMS) that reported about 2.9 million subscribers as of June 30, 2026 in its quarterly report. It has faced regulatory scrutiny over compounded semaglutide, including FDA warning letters in September 2025 and an FDA statement naming the company in February 2026.

How much does Hims weight loss cost per month?

hims.com blocked our automated checks on Nov 4, 2026, so we could not confirm current Hims prices. For brand-name reference, NovoCare self-pay pricing for Wegovy was $149 to $299 a month for the pill and $349 a month for most pen doses after a $199 intro offer. Any Hims membership fee would be on top of medication.

Does Hims offer tirzepatide (Mounjaro/Zepbound)?

The March 2026 announcement listed only Novo Nordisk products (Wegovy and Ozempic). We could not confirm whether Hims currently offers Zepbound. Zepbound self-pay through LillyDirect starts at $299/month for the 2.5 mg dose.

Can I cancel Hims weight loss anytime?

We could not read Hims’ current cancellation terms on Nov 4, 2026. Before you sign up, find your renewal date and cancellation cutoff in the terms, and keep written confirmation of any cancellation.

Is Hims’ compounded semaglutide still available?

Only on a limited scale. Hims & Hers said in March 2026 it would stop advertising compounded GLP-1s and offer them only when a provider determines a compounded product is clinically necessary.

Related

Guides:

• Cheapest Way to Get GLP-1 Online
• GLP-1 Side Effects Month by Month
• How to Get Insurance to Cover GLP-1 Meds
• Compounded vs Brand-Name GLP-1
• Oral vs Injectable GLP-1

Provider Reviews: Ro Review · Found Review · Noom Review · Henry Meds Review · Eden Review

Compare: All Providers · Best GLP-1 Programs 2026

What we checked

This AI-assisted public-source desk check reviewed the Hims & Hers March 2026 press release and June 2026 quarterly report on SEC EDGAR, FDA statements on compounded GLP-1s, NovoCare and LillyDirect self-pay pricing, the Wegovy prescribing information and the SURMOUNT-5 trial abstract on November 4, 2026. hims.com blocked automated access, so we could not confirm Hims prices. We did not complete signup, pay for treatment, test delivery or support, or independently verify clinician and pharmacy credentials. Prices and policies change, so confirm them with the provider or your prescriber before you act.